SG11202007470QA - Modified adenoviruses - Google Patents

Modified adenoviruses

Info

Publication number
SG11202007470QA
SG11202007470QA SG11202007470QA SG11202007470QA SG11202007470QA SG 11202007470Q A SG11202007470Q A SG 11202007470QA SG 11202007470Q A SG11202007470Q A SG 11202007470QA SG 11202007470Q A SG11202007470Q A SG 11202007470QA SG 11202007470Q A SG11202007470Q A SG 11202007470QA
Authority
SG
Singapore
Prior art keywords
modified adenoviruses
adenoviruses
modified
Prior art date
Application number
SG11202007470QA
Inventor
Alan Parker
Hanni Uusi-Kerttula
Original Assignee
Univ College Cardiff Consultants Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ College Cardiff Consultants Ltd filed Critical Univ College Cardiff Consultants Ltd
Publication of SG11202007470QA publication Critical patent/SG11202007470QA/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/76Viruses; Subviral particles; Bacteriophages
    • A61K35/761Adenovirus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011Details
    • C12N2710/10011Adenoviridae
    • C12N2710/10311Mastadenovirus, e.g. human or simian adenoviruses
    • C12N2710/10321Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011Details
    • C12N2710/10011Adenoviridae
    • C12N2710/10311Mastadenovirus, e.g. human or simian adenoviruses
    • C12N2710/10322New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011Details
    • C12N2710/10011Adenoviridae
    • C12N2710/10311Mastadenovirus, e.g. human or simian adenoviruses
    • C12N2710/10332Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011Details
    • C12N2710/10011Adenoviridae
    • C12N2710/10311Mastadenovirus, e.g. human or simian adenoviruses
    • C12N2710/10341Use of virus, viral particle or viral elements as a vector
    • C12N2710/10345Special targeting system for viral vectors
SG11202007470QA 2018-02-16 2019-02-13 Modified adenoviruses SG11202007470QA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB1802539.5A GB201802539D0 (en) 2018-02-16 2018-02-16 Modified adenoviruses
PCT/GB2019/050380 WO2019158914A1 (en) 2018-02-16 2019-02-13 Modified adenoviruses

Publications (1)

Publication Number Publication Date
SG11202007470QA true SG11202007470QA (en) 2020-09-29

Family

ID=61783770

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11202007470QA SG11202007470QA (en) 2018-02-16 2019-02-13 Modified adenoviruses

Country Status (15)

Country Link
US (1) US20210100855A1 (en)
EP (1) EP3737403B1 (en)
JP (2) JP2021513843A (en)
KR (1) KR20200122346A (en)
CN (1) CN112020368A (en)
AU (1) AU2019220607B2 (en)
CA (1) CA3090859A1 (en)
DK (1) DK3737403T3 (en)
FI (1) FI3737403T3 (en)
GB (1) GB201802539D0 (en)
IL (1) IL276535A (en)
PL (1) PL3737403T3 (en)
PT (1) PT3737403T (en)
SG (1) SG11202007470QA (en)
WO (1) WO2019158914A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014153204A1 (en) 2013-03-14 2014-09-25 Salk Institute For Biological Studies Oncolytic adenovirus compositions
JP7015551B2 (en) 2016-02-23 2022-02-15 ソーク インスティテュート フォー バイオロジカル スタディーズ Exogenous gene expression in therapeutic adenovirus to minimize its impact on viral dynamics
CA3013637A1 (en) 2016-02-23 2017-08-31 Salk Institute For Biological Studies High throughput assay for measuring adenovirus replication kinetics
WO2018111767A1 (en) 2016-12-12 2018-06-21 Salk Institute For Biological Studies Tumor-targeting synthetic adenoviruses and uses thereof
AU2022247189A1 (en) * 2021-03-29 2023-09-14 University College Cardiff Consultants Limited Modified adenovirus
GB202214580D0 (en) 2022-10-04 2022-11-16 Univ College Cardiff Consultants Ltd Adenoviral vector therapy

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1613757A2 (en) * 2003-03-28 2006-01-11 The Scripps Research Institute Adenovirus particles with enhanced infectivity of dendritic cells and particles with decreased infectivity of hepatocytes
GB0520068D0 (en) * 2005-10-03 2005-11-09 Cancer Res Technology av peptide ligand
ES2367227T3 (en) * 2007-03-14 2011-10-31 Institut Catala D'oncologia ADENOVIRUS WITH MUTATIONS IN THE RETENTION DOMAIN IN THE ENDOPLASMATTIC RETICLE OF PROTEIN E3-19K AND ITS USE IN THE TREATMENT OF CANCER.
US20110104788A1 (en) * 2008-02-07 2011-05-05 Andrew Baker Modulation of Adenoviral Tropism
CA2812096A1 (en) * 2010-09-24 2012-03-29 Oncos Therapeutics Oy Adenoviral vectors and methods and uses related thereto
WO2016118433A1 (en) * 2015-01-20 2016-07-28 Shayakhmetov Dmitry M Detargeted adenovirus variants and related methods

Also Published As

Publication number Publication date
PL3737403T3 (en) 2024-03-18
CA3090859A1 (en) 2019-08-22
DK3737403T3 (en) 2024-01-22
CN112020368A (en) 2020-12-01
EP3737403B1 (en) 2024-01-03
US20210100855A1 (en) 2021-04-08
PT3737403T (en) 2024-01-24
AU2019220607A1 (en) 2020-09-17
JP2021513843A (en) 2021-06-03
KR20200122346A (en) 2020-10-27
EP3737403A1 (en) 2020-11-18
JP2024020345A (en) 2024-02-14
IL276535A (en) 2020-09-30
FI3737403T3 (en) 2024-01-17
AU2019220607B2 (en) 2024-02-15
WO2019158914A1 (en) 2019-08-22
GB201802539D0 (en) 2018-04-04

Similar Documents

Publication Publication Date Title
DK3793565T3 (en) Mcl-1-inhibitorer
DK3467457T3 (en) Vibrationssensor
DK3759096T3 (en) Cd73-inhibitorer
CA185383S (en) Casque
CA185382S (en) Casque
CA185384S (en) Casque
IL288283A (en) Modified adenoviruses
CA185385S (en) Casque
IL276535A (en) Modified adenoviruses
DK3773537T3 (en) Stat3-hæmmere
DK3554057T3 (en) Audioheadsetsystem
DK3768830T3 (en) Cancerterapi
ZA202005848B (en) Modified oncolytic adenoviruses
DK3613739T3 (en) Integrin-antagonister
DK3753395T3 (en) Indvendigt luftstyringssystem
CA184991S (en) Uroflowmeter
DK3872428T3 (en) Indvendigt luftstyringssystem
DK3633783T3 (en) Universal-powerbank
CA184993S (en) Uroflowmeter
EP3766087C0 (en) Sensformer
EP3841303C0 (en) Microblower
DK3768906T3 (en) Træmodul
DK3650069T3 (en) Trakeostomiventil
DK3570498T3 (en) Adaptivt hvac-styresystem
DK3674425T3 (en) Stålwire